(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Pipeline Review, H2 2016', provides in depth analysis on Dual Specificity Mitogen Activated Protein Kinase Kinase...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H1 2016', provides in depth analysis on DNA Gyrase Subunit B (EC 5.99.1.3) targeted pipeline therapeutics. The report provides comprehensive information on the DNA Gyrase Subunit B (EC 5.99.1.3),...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Cell Division Cycle 7 Related Protein Kinase (CDC7-Related Kinase or HsCdc7 or EC 2.7.11.1) - Pipeline Review, H1 2016', provides in depth analysis on Cell Division Cycle 7 Related Protein Kinase (CDC7-Related Kinase or HsCdc7 or EC 2.7.11.1)...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Pipeline Review, H1 2016', provides in depth analysis on Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) targeted pipeline therapeutics. The report provides comprehensive information...
(Health-NewsWire.Net, October 28, 2016 ) Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2016SummaryPublisher's, 'Beta Secretase 1 (Aspartyl Protease...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H2 2016', provides in depth analysis on Beta Nerve Growth Factor (Beta NGF or NGF) targeted pipeline therapeutics. The report provides comprehensive information on the Beta Nerve Growth...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016', provides in depth analysis on Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016', provides in depth analysis on Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016', provides in depth analysis on Angiopoietin 2 (Ang 2 or ANGPT2) targeted pipeline therapeutics. The report provides comprehensive information on the Angiopoietin 2 (Ang 2 or ANGPT2),...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Alpha-N-Acetylglucosaminidase (N-Acetyl-Alpha-Glucosaminidase or NAG or EC 3.2.1.50) - Pipeline Review, H1 2016', provides in depth analysis on Alpha-N-Acetylglucosaminidase (N-Acetyl-Alpha-Glucosaminidase or NAG or EC 3.2.1.50) targeted pipeline...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, 'Alpha-2C Adrenergic Receptor (Alpha-2 Adrenergic Receptor Subtype C4 or Alpha-2C Adrenoreceptor or ADRA2C or ADRA2RL2) - Pipeline Review, H1 2016', provides in depth analysis on Alpha-2C Adrenergic Receptor (Alpha-2 Adrenergic Receptor Subtype...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, '72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or MMP2 or EC 3.4.24.24) - Pipeline Review, H1 2016', provides in depth analysis on 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase...
(Health-NewsWire.Net, October 28, 2016 ) DelveInsight's, "Vasopressin Receptor Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Vasopressin Receptor Antagonists. The DelveInsight's Report covers the product profiles...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, "Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors. The...
(Health-NewsWire.Net, October 28, 2016 ) Publisher's, "Toll-Like Receptor 4 (TLR-4) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Toll-Like Receptor 4 (TLR-4) Agonists. The Publisher's Report covers the product...
|